Erratum: Aspirin Has a Neutral Effect in Preventing Future Cardiovascular Events in Vasospastic Angina

Cardiovascular Prevention and Pharmacotherapy
doi 10.36011/cpp.2020.2.e1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Society of Cardiovascular Disease Prevention

Related search

Aspirin Use and Cardiovascular Events in Social Networks

Social Science and Medicine
MedicinePhilosophy of ScienceHealthHistory
2012English

Successful Use of Ranolazine in a Patient With Vasospastic Angina

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Vasospastic Angina: Pathophysiology and Clinical Significance

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2020English

The Place of Diuretics in Preventing Cardiovascular Events

Journal of Human Hypertension
Internal Medicine
2004English

Vasospastic Angina: Pathophysiology and Clinical Significance

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2020English

Aspirin for Primary Prevention of Cardiovascular Events

Journal of General Internal Medicine
Internal Medicine
1998English

4. The Second and the Third Types of Angina: Vasospastic Angina and Microvascular Angina

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Refractory Vasospastic Angina: When Typical Medications Don't Work

Cureus
2019English

Effect of Aspirin on C- Reactive Protein as a Marker of Risk in Unstable Angina

IOSR Journal of Pharmacy and Biological Sciences
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy